These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 34967284

  • 21. Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity.
    Dragun D, Catar R, Philippe A.
    Kidney Int; 2016 Aug; 90(2):280-288. PubMed ID: 27188505
    [Abstract] [Full Text] [Related]

  • 22. Angiotensin II receptor 1 antibodies associate with post-transplant focal segmental glomerulosclerosis and proteinuria.
    Abuzeineh M, Aala A, Alasfar S, Alachkar N.
    BMC Nephrol; 2020 Jul 02; 21(1):253. PubMed ID: 32615995
    [Abstract] [Full Text] [Related]

  • 23. Clinical implications of angiotensin II type 1 receptor antibodies in antibody-mediated rejection without detectable donor-specific HLA antibodies after renal transplantation.
    Lee J, Park Y, Kim BS, Lee JG, Kim HJ, Kim YS, Huh KH.
    Transplant Proc; 2015 Apr 02; 47(3):649-52. PubMed ID: 25891704
    [Abstract] [Full Text] [Related]

  • 24. The role of endothelin II type A receptor (ETAR) in transplant injury.
    Nowańska K, Wiśnicki K, Kuriata-Kordek M, Krajewska M, Banasik M.
    Transpl Immunol; 2022 Feb 02; 70():101505. PubMed ID: 34793957
    [Abstract] [Full Text] [Related]

  • 25. Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies.
    Taniguchi M, Rebellato LM, Cai J, Hopfield J, Briley KP, Haisch CE, Catrou PG, Bolin P, Parker K, Kendrick WT, Kendrick SA, Harland RC, Terasaki PI.
    Am J Transplant; 2013 Oct 02; 13(10):2577-89. PubMed ID: 23941128
    [Abstract] [Full Text] [Related]

  • 26. Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients.
    Fichtner A, Süsal C, Höcker B, Rieger S, Waldherr R, Westhoff JH, Sander A, Dragun D, Tönshoff B.
    Pediatr Nephrol; 2021 Aug 02; 36(8):2473-2484. PubMed ID: 33759004
    [Abstract] [Full Text] [Related]

  • 27. Non-HLA antibodies targeting vascular receptors enhance alloimmune response and microvasculopathy after heart transplantation.
    Hiemann NE, Meyer R, Wellnhofer E, Schoenemann C, Heidecke H, Lachmann N, Hetzer R, Dragun D.
    Transplantation; 2012 Nov 15; 94(9):919-24. PubMed ID: 23034559
    [Abstract] [Full Text] [Related]

  • 28. Endothelin Type A Receptor Antibodies Are Associated With Angiotensin II Type 1 Receptor Antibodies, Vascular Inflammation, and Decline in Renal Function in Pediatric Kidney Transplantation.
    Pearl MH, Chen L, ElChaki R, Elashoff D, Gjertson DW, Rossetti M, Weng PL, Zhang Q, Reed EF, Chambers ET.
    Kidney Int Rep; 2020 Nov 15; 5(11):1925-1936. PubMed ID: 33163713
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome.
    Reinsmoen NL, Lai CH, Mirocha J, Cao K, Ong G, Naim M, Wang Q, Haas M, Rafiei M, Czer L, Patel J, Kobashigawa J.
    Transplantation; 2014 Mar 15; 97(5):595-601. PubMed ID: 24162250
    [Abstract] [Full Text] [Related]

  • 32. Antibody-Mediated Rejection in Kidney Transplantation Without Evidence of Anti-HLA Antibodies?
    Irure J, López-Hoyos M, Rodrigo E, Gómez-Román J, Ruiz JC, Arias M, San Segundo D.
    Transplant Proc; 2016 Nov 15; 48(9):2888-2890. PubMed ID: 27932099
    [Abstract] [Full Text] [Related]

  • 33. Histopathologic changes in anti-angiotensin II type 1 receptor antibody-positive kidney transplant recipients with acute rejection and no donor specific HLA antibodies.
    Lim MA, Palmer M, Trofe-Clark J, Bloom RD, Jackson A, Philogene MC, Kamoun M.
    Hum Immunol; 2017 Apr 15; 78(4):350-356. PubMed ID: 28284829
    [Abstract] [Full Text] [Related]

  • 34. The impact of angiotensin II type 1 receptor antibodies on post-heart transplantation outcome in Heart Mate II bridged recipients.
    Urban M, Slavcev A, Gazdic T, Ivak P, Besik J, Netuka I.
    Interact Cardiovasc Thorac Surg; 2016 Mar 15; 22(3):292-7. PubMed ID: 26675563
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.
    Cuevas E, Arreola-Guerra JM, Hernández-Méndez EA, Salcedo I, Castelán N, Uribe-Uribe NO, Vilatobá M, Contreras-Saldívar AG, Sánchez-Cedillo AI, Ramírez JB, de Rungs D, Granados J, Morales-Buenrostro LE, Alberú J.
    Nephrol Dial Transplant; 2016 Oct 15; 31(10):1738-45. PubMed ID: 27220757
    [Abstract] [Full Text] [Related]

  • 37. Accelerated rejection, thrombosis, and graft failure with angiotensin II type 1 receptor antibodies.
    Pearl MH, Leuchter RK, Reed EF, Zhang Q, Ettenger RB, Tsai EW.
    Pediatr Nephrol; 2015 Aug 15; 30(8):1371-4. PubMed ID: 25956702
    [Abstract] [Full Text] [Related]

  • 38. Non-HLA antibodies in solid organ transplantation: recent concepts and clinical relevance.
    Dragun D, Catar R, Philippe A.
    Curr Opin Organ Transplant; 2013 Aug 15; 18(4):430-5. PubMed ID: 23838648
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients.
    Reinsmoen NL, Lai CH, Heidecke H, Haas M, Cao K, Ong G, Naim M, Wang Q, Mirocha J, Kahwaji J, Vo AA, Jordan SC, Dragun D.
    Transplantation; 2010 Dec 27; 90(12):1473-7. PubMed ID: 21030904
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.